The present disclosure relates to methods of treatment for various diseases, including burn and chronic obstructive pulmonary disease, involving administration of compositions comprising membrane-enclosed vesicles. The membrane-enclosed vesicles may be derived from a stem cell such as a mesenchymal stem cell.